Advertisement

You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Pharmacists' Report

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

October 3, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Study says dapagliflozin works well for T2DM

In adult patients with type 2 diabetes mellitus who are uncontrolled on metformin and sulfonylurea, dapagliflozin can be added to help improve HbA1c and reduce fasting plasma glucose, body weight, and seated systolic blood pressure, according to a study presented at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain. » More

Digoxin poses higher death risk for heart patients

Digoxin, commonly used to treat heart conditions, was associated with a 72% higher rate of death among adults with newly diagnosed heart failure, according to a Kaiser Permanente study in the September issue of Circulation: Cardiovascular Quality and Outcomes. » More

ADVERTISEMENT

The Obesity Epidemic
More than 78 million U.S. adults and 12 million children and adolescents are obese, and those numbers increase every day. Articles, video, whitepapers, and resources to help you adapt your practice to confront the growing epidemic.

Cognitive enhancers for MCI don't work for long term

Cognitive enhancers—drugs taken to enhance concentration, memory, alertness, and moods— that are often given to patients with Alzheimer's disease do not improve cognition or function for those with mild cognitive impairment in the long term—about 96 weeks, according to a study published recently in the Canadian Medical Association Journal. » More

1st anti-IL-12/23 psoriatic arthritis drug approved

FDA has approved ustekinumab (Stelara, Janssen Biotech) alone or in combination with methotrexate for active psoriatic arthritis in adult patients aged 18 years and older. » More

ADVERTISEMENT

UCONN offers live MTM for diabetes event Nov. 9
The University of Connecticut School of Pharmacy and Drug Topics present the live event "Medication Therapy Management for Patients with Diabetes" on Saturday, November 9, at the Lincoln Medical and Mental Health Center in Bronx, N.Y. Learn motivational interviewing skills and apply MTM concepts to patients with diabetes to earn 7 CPE credits. Practice your skills after this program to earn another 6 CPE credits and a Certificate in MTM for the Patient with Diabetes!
For more information about pre-requisites and to register, go to
http://pharmacy.uconn.edu/academics/ce/mtm-for-patients-with-dm.

Continuing Education

New Mini-Series: Osteoporosis Care

This month, Drug Topics offers the first part of a two-part CPE series, "MTM considerations in osteoporosis care." Earn up to 2 credits by completing this application-based activity.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

 
Advertisement

Check these out, too

Pharmacy best major for lucrative job

NACDS, NCPA endorse compounding bill

APhA offers Rx synchronization tool kit

New website lists wholesale price of drugs

Voices

Anticoagulation Update

JP at Large

View from the Zoo

Viewpoints

Regulatory and Legal

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group